Insmed (NASDAQ:INSM) reported quarterly losses of $(1.42) per share which missed the analyst consensus estimate of $(1.33) by 6.77 percent. This is a 33.96 percent decrease over losses of $(1.06) per share from the same period last year. The company reported quarterly sales of $92.82 million which beat the analyst consensus estimate of $92.08 million by 0.81 percent. This is a 22.94 percent increase over sales of $75.50 million the same period last year.